Yong Yu

Chief Scientific Officer; SVP, Clinical Development · 2 filings · Latest: May 11, 2026

GENELUX Corp

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
GNLX	Yong Yu	Chief Scientific Officer	May 11, 2026	Sale	$2.97	605	$1.8K	149,706	May 13 12:30 AM
GNLX	Yong Yu	SVP, Clinical Development	Mar 24, 2026	Sale	$2.42	906	$2.2K	144,938	Mar 26 9:00 PM